fda warning letter glp-1 solution september 2025 The U.S. Food and Drug Administration (FDA) has issued a to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its medications FDA ramps up its pushback

For example, in the SELECT trial (17,600 patients with cardiovascular disease and obesity but without T2D), weekly subcutaneous Semaglutide (2.4 mg) reduced the risk of major adverse cardiovascular events (MACE heart attack, stroke, or cardiovascular death) by 20% compared to placebo (HR 0.80

Certain probiotic strains have clinical evidence for improving bowel frequency, abdominal pain, and other symptoms related to IBS

Good to know, clinical studies have also demonstrated that enzyme supplementation can improve recovery after exercise by regulating inflammation

While the cause of autism remains elusive, studies had shown that the cells of those with ASD often demonstrated high levels of oxidative stress, something sulforaphane does a good job of protecting against

Moderate age-related decline necessitates more stimulation than younger patients but most retain adequate pituitary reserve for good response